Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "author" (Boris Jančar) .

1 - 10 / 26
First pagePrevious page123Next pageLast page
1.
Acrospiroma of the left temporal region
Boris Jančar, 2009, other component parts

Published in DiRROS: 08.03.2024; Views: 54; Downloads: 20
.pdf Full text (433,26 KB)

2.
Extensive squamous cell carcinoma of the lower lid
Boris Jančar, 2008, professional article

Published in DiRROS: 08.03.2024; Views: 65; Downloads: 20
.pdf Full text (99,83 KB)

3.
Planocellular carcinoma of the right cheek
Boris Jančar, 2008, professional article

Published in DiRROS: 07.03.2024; Views: 67; Downloads: 19
.pdf Full text (227,74 KB)

4.
Basal cell carcinoma in the inner canthus
Boris Jančar, 2007, other component parts

Published in DiRROS: 22.02.2024; Views: 143; Downloads: 20
.pdf Full text (73,71 KB)

5.
Recurrence of carcinoma of the lower lip treated by interferon and irradiation
Boris Jančar, 2007, professional article

Published in DiRROS: 21.02.2024; Views: 395; Downloads: 31
.pdf Full text (97,73 KB)

6.
Mb. Bowen and squamous-cell carcinoma on the eczematous skin
Boris Jančar, 2007, professional article

Published in DiRROS: 20.02.2024; Views: 95; Downloads: 20
.pdf Full text (131,84 KB)

7.
Basal cell carcinoma on the left cheek
Boris Jančar, 2007, professional article

Published in DiRROS: 20.02.2024; Views: 94; Downloads: 25
.pdf Full text (1,83 MB)

8.
Carcinoma of the lower lip
Boris Jančar, 2006, professional article

Published in DiRROS: 15.02.2024; Views: 111; Downloads: 19
.pdf Full text (1,03 MB)

9.
Preoperative concomitant chemoradiotherapy in esophageal cancer
Boštjan Šeruga, Mihael Sok, Janez Eržen, Jože Jerman, Boris Jančar, Branko Zakotnik, 2006, original scientific article

Abstract: Background. Currently primary treatment options for esophageal cancer are surgery only or concomitant chemoradiotherapy (CRT) and the long-term survivalof patients with locally advanced disease is rare. Preoperative concomitant CRT seems to be beneficial, mostly in patients who achieve a complete pathologic response (pCR) after CRT. In this retrospective analysis the efficiency and toxicity of preoperative CRT in patients with locally advanced esophageal cancer was analysed as well as the influence of pCR on thesuraival. Patients and metkods From 1996 to 2002 41 patients with locoregionally confined esophageal cancerwere treated with cisplatin 75 mgžm2 and 5-FU 1000 mgžm2 as 4 day contonuous infusion starting on days 1. and 22. with concorrtitant radiotherapy 4500 cGy, 200-300 cGyžday. Esophagectomy followed 4-5 weeks after radiotherapy. After the surgery patients were followed-up regularly at 3-6 months intervals. Results. The pCR was achieved in 26.8% of patients. The overall median survival time was 18 months for all patients, 21.2 months for patients who achieved pCR and 16 months in those with residual disease (p= 0,79). Postoperative mortality rate was 22%. The median dose intensity for cisplatin was 92% and for 5-FU 71.5 of the planned dose. Disease recurred most often locoregionally (31.7%) and the overall recurrence rate was 43.9. Conclusion. Modern radiation techniques and the adequate dose intensity could further improve the locoregional control. The selection of patients without comorbid conditions and without already present distant metastases is essential for this combined treatment approach.
Published in DiRROS: 15.02.2024; Views: 100; Downloads: 25
.pdf Full text (123,83 KB)

10.
Brachytherapy (Ru 106) in the treatment of malignant melanoma of the choroid
Boris Jančar, K... Andrejčič, Primož Logar, Irena-Hedvika Brovet-Zupančič, 1997, published scientific conference contribution abstract

Published in DiRROS: 18.01.2024; Views: 145; Downloads: 35
.pdf Full text (1,10 MB)

Search done in 0.33 sec.
Back to top